A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease

Project: Research

Project Details

StatusActive
Effective start/end date7/09/2131/12/24

Keywords

  • Alzheimer's disease
  • Neurodegenerative diseases
  • Clinical trial